Nevertheless, SFRP2 methylation may be potentially useful as a molecular tumor biomarker in a DNA methylation biomarker based screening assay, as it may display high clinical sensitivity and specificity in detecting breast cancer cells. This evidence concerns the gene SFRP2 and breast carcinoma.